Publication | Open Access
Inhibition of CDK9 attenuates atherosclerosis by inhibiting inflammation and phenotypic switching of vascular smooth muscle cells
11
Citations
22
References
2021
Year
These results indicate that inhibition of CDK9 may be a novel therapeutic target for the prevention of atherosclerosis.
| Year | Citations | |
|---|---|---|
Page 1
Page 1